POTENTIAL GOLDEN CROSS
An extrapolation of MEDIPHARM LABS' 50-day and 200-day moving average lines suggests a GOLDEN CROSS should take place early next year.
According to The Globe and Mail, the target price for LABS is $0.10:
https://www.theglobeandmail.com/investing/markets/stocks/LABS-T/research/
This represents a 20% upside potential.
GLTA!
According to The Globe and Mail, the target price for LABS is $0.10:
https://www.theglobeandmail.com/investing/markets/stocks/LABS-T/research/
This represents a 20% upside potential.
GLTA!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.